New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:21 EDTPKI, DDXS, WAT, PACB, AFFX, SQNM, FLDMMaxim recommends life science tools, diagnostics ahead of earnings
Maxim expects 2014 to be a "great year" for life science tools and diagnostics stocks and recommends buying Affymetrix (AFFX), diaDexus (DDXS), Fluidigm (FLDM), Pacific Biosciences (PACB), PerkinElmer (PKI), Sequenom (SQNM) and Waters (WAT) ahead of the Q4 results. Maxim has a preference for Pacific Biosciences, PerkinElmer and Waters. The firm raised its price target for Fluidigm to $52 from $42 and for Pacific Biosciences to $9 from $8.
News For AFFX;DDXS;FLDM;PACB;PKI;SQNM;WAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:02 EDTWAT, PKIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
December 16, 2014
16:16 EDTPKIPerkinElmer initiated with a Buy at KeyBanc
Target $52.
16:16 EDTWATWaters initiated with a Hold at KeyBanc
09:33 EDTPKIPerkinElmer downgraded to Neutral from Buy at Cleveland Research
Subscribe for More Information
December 15, 2014
17:16 EDTPKIFDA approves marketing of EnLite Neonatal TREC Kit
Subscribe for More Information
16:47 EDTDDXSdiaDexus receives FDA clearance for PLAC activity test
diaDexus announced that it has received 510(k) clearance from the FDA for its PLAC Test for Lp-PLA2 Activity. This new test is an enzyme assay for the quantitative determination of Lp-PLA2 activity in human plasma and serum. An analysis based on REGARDS, a U.S.-based National Institutes of Health-funded longitudinal study, using a cohort of approximately 4,500 individuals with no prior history of cardiovascular events, demonstrated that elevated Lp-PLA2 Activity levels are associated with a significant increase for risk of coronary heart disease. To commercialize this new test, diaDexus will use its established salesforce. Beginning in 1Q15, the company expects to start contracting and enabling new lab customers.
15:10 EDTDDXSFDA clears diaDexus screening test for coronary heart disease risk
Subscribe for More Information
December 8, 2014
07:26 EDTFLDM, AFFXLeerink to hold a tour
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use